Zydus gets 180 days’ shared exclusivity for Roflumilast tablets EP News Bureau Feb 14, 2022 Zydus’ Roflumilast tablets are indicated as a treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD)…
